![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/saol-therapeutics-announces-completion-of-enrollment-in-both-the-phase-ii-compass-osteoarthritis-knee-pain-trial-and-the-phase-ii-raise-limb-spasticity-trial-301930918.html
https://www.prnewswire.com/news-releases/saol-therapeutics-announces-enrollment-achievement-in-pivotal-phase-3-trial-for-rare-mitochondrial-disease--pyruvate-dehydrogenase-complex-deficiency-pdcd-301638162.html
https://www.clinicaltrialsarena.com/news/saol-trial-knee-pain/
https://www.prnewswire.com/news-releases/saol-therapeutics-announces-first-patient-enrolled-in-phase-2-compass-trial-evaluating-the-safety-and-efficacy-profile-of-sl-1002-for-treatment-of-knee-pain-associated-with-osteoarthritis-301602027.html